Institutional
Euclidean Capital LLC
CIK 0001825034
$392.3M
Reported AUM
10
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | VEU | VANGUARD INTL EQUITY INDEX F | $243.6M | 62.09% | +253,400 | +8.5% |
| 2 | VTV | VANGUARD INDEX FDS | $102.0M | 26.01% | — | HELD |
| 3 | INDA | ISHARES TR | $17.3M | 4.41% | — | HELD |
| 4 | ORIC | ORIC PHARMACEUTICALS INC | $12.5M | 3.20% | — | HELD |
| 5 | FHTX | FOGHORN THERAPEUTICS INC | $7.5M | 1.92% | — | HELD |
| 6 | PMVP | PMV PHARMACEUTICALS INC | $3.3M | 0.83% | — | HELD |
| 7 | ALEC | ALECTOR INC | $2.8M | 0.72% | — | HELD |
| 8 | SRZN | SURROZEN INC | $2.6M | 0.65% | — | HELD |
| 9 | TNYA | TENAYA THERAPEUTICS INC | $703K | 0.18% | — | HELD |
| 10 | SRZNW | SURROZEN INC | $3K | 0.00% | — | HELD |
| 11 | SPY | SPDR S&P 500 ETF TR | — | — | -4,104 | EXITED |
| 12 | RAPT | RAPT THERAPEUTICS INC | — | — | -82,234 | EXITED |
Source: SEC EDGAR · accession 0001012975-26-000442. 13F discloses long positions only — shorts, foreign equities, and options are excluded.